行动心电遥测市场规模、份额和成长分析(按应用、类型和地区划分)—2026-2033年产业预测
市场调查报告书
商品编码
1905922

行动心电遥测市场规模、份额和成长分析(按应用、类型和地区划分)—2026-2033年产业预测

Mobile Cardiac Telemetry Market Size, Share, and Growth Analysis, By Application (lead based, patch based), By Type (Hospitals, cardiac centres), By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 260 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球行动心电遥测市场规模预计在 2024 年达到 10.1 亿美元,从 2025 年的 11.3 亿美元增长到 2033 年的 28.2 亿美元,在预测期(2026-2033 年)内复合年增长率为 12.1%。

行动心电遥测(MCT) 系统是携带式心臟监测领域的最尖端科技,可提供先进的即时分析,从而降低门诊病人心电图诊断的相关成本。这些小巧便携的设备提高了病患和医护人员的诊疗效率。心血管疾病 (CVD) 的日益普遍,以及 MCT 监测的许多益处,正在推动老龄化社会中市场的成长。心血管疾病涵盖多种严重的心血管疾病,而吸烟和不良饮食等生活方式因素会进一步加剧患病风险,凸显了有效监测解决方案的紧迫性。 MCT 系统利用患者佩戴的小型感测器,在发生心臟事件时传输数据以供即时分析。详细的报告有助于医生提高诊断准确性和治疗管理水平。

全球行动心电遥测市场驱动因素

全球行动心电遥测市场的成长主要得益于人们对创新贴片技术的认知不断提高,以及应用更广泛的新型设备的研发。这种认知的提升促使医疗服务提供者和患者更多地采用这些先进的解决方案,从而增强了监测能力并改善了患者的治疗效果。随着越来越多的医疗专业人员认识到移动心电遥测的优势,对这些系统的需求持续增长,推动了技术进步,并拓展了市场机会。因此,这一上升趋势正在重塑心臟监测和护理的未来模式。

限制全球移动心电遥测市场发展的因素

尖端行动心电遥测设备的高昂成本可能会阻碍其在医疗保健领域的广泛应用。因此,此经济障碍对全球移动心电遥测市场的扩张构成挑战。这些先进系统的高昂价格限制了许多医疗机构的取得途径,最终影响他们有效采用和利用此类技术的能力。因此,这项阻碍因素会减缓创新和应用的速度,影响行动心电遥测解决方案在各种医疗环境中的整体成长潜力。解决这些成本相关问题对于市场的发展至关重要。

全球行动心电遥测市场趋势

全球行动心臟遥测市场呈现稳定上升趋势,主要得益于技术进步,使得心臟监测更方便有效率。随着医疗保健模式向以患者为中心的方向转变,能够为心臟病患者提供持续即时数据传输的行动系统需求激增。这些系统不仅提升了病患的活动能力,也能方便医护人员及时进行医疗介入。行动心电遥测中先进分析和连接功能的整合进一步推动了市场成长,因为相关人员认识到远端监测的价值,并认可其对改善患者预后和降低医疗成本的贡献。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2025)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析

全球行动心电遥测市场规模(按应用及复合年增长率划分)(2026-2033 年)

  • 主音贝斯
  • 基于补丁

全球行动心电遥测市场规模(按类型和复合年增长率划分)(2026-2033 年)

  • 医院
  • 心臟中心
  • 其他的

全球行动心电遥测市场规模及复合年增长率(2026-2033)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2025 年)
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Medtronic plc(Ireland)
  • Koninklijke Philips NV(Netherlands)
  • iRhythm Technologies, Inc.(USA)
  • Preventice Solutions(USA)
  • Boston Scientific Corporation(USA)
  • ScottCare Corporation(USA)
  • Applied Cardiac Systems, Inc.(USA)
  • Medicomp, Inc.(USA)
  • CardioNet, Inc.(USA)
  • LifeWatch AG(Switzerland)
  • Bittium Corporation(Finland)
  • GE Healthcare(USA)
  • Siemens Healthineers AG(Germany)
  • Hillrom Holdings, Inc.(USA)
  • Baxter International Inc.(USA)
  • AliveCor, Inc.(USA)
  • InfoBionic, Inc.(USA)

结论与建议

简介目录
Product Code: SQMIG35A2202

Global Mobile Cardiac Telemetry Market size was valued at USD 1.01 Billion in 2024 and is poised to grow from USD 1.13 Billion in 2025 to USD 2.82 Billion by 2033, growing at a CAGR of 12.1% during the forecast period (2026-2033).

Mobile Cardiac Telemetry (MCT) systems are at the forefront of ambulatory cardiac monitoring, offering advanced real-time analysis that lowers costs associated with electrocardiographic diagnosis for outpatients. These compact, portable devices enhance care efficiency for both patients and healthcare providers. The increasing prevalence of cardiovascular diseases (CVDs), alongside the benefits of MCT monitoring, fuels market growth, driven by an aging population. As CVDs encompass significant heart and blood vessel disorders, lifestyle factors such as tobacco use and poor diet further exacerbate risks, highlighting the urgent need for effective monitoring solutions. MCT systems utilize small sensors worn by patients, transmitting data for immediate analysis during cardiac events and improving diagnostic accuracy and therapeutic management through detailed reporting for physicians.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mobile Cardiac Telemetry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mobile Cardiac Telemetry Market Segments Analysis

Global Mobile Cardiac Telemetry Market is segmented by Application, Type and region. Based on Application, the market is segmented into lead based and patch based. Based on Type, the market is segmented into Hospitals, cardiac centres and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mobile Cardiac Telemetry Market

The growth of the global mobile cardiac telemetry market is being fueled by a heightened awareness of innovative patch technology and the development of new devices featuring enhanced applications. This awareness is encouraging both healthcare providers and patients to adopt these advanced solutions, thereby improving monitoring capabilities and fostering better patient outcomes. As more medical professionals recognize the benefits of mobile cardiac telemetry, the demand for these systems continues to rise, leading to advancements in technology and expanded opportunities within the market. Consequently, this upward trend is shaping the future landscape of cardiac monitoring and care.

Restraints in the Global Mobile Cardiac Telemetry Market

The significant expense associated with cutting-edge mobile cardiac telemetry devices can hinder their widespread adoption within the healthcare sector. As a result, this financial barrier poses a challenge to the expansion of the global mobile cardiac telemetry market. The high prices of these advanced systems may lead to limited accessibility for many healthcare providers, ultimately affecting their ability to implement and utilize such technologies effectively. Consequently, this restraint could slow down innovation and deployment, impacting the overall growth potential of mobile cardiac telemetry solutions in various healthcare settings. Addressing these cost-related issues will be crucial for market advancement.

Market Trends of the Global Mobile Cardiac Telemetry Market

The Global Mobile Cardiac Telemetry market is witnessing a robust upward trend driven by advancements in technology, which enhance the convenience and efficiency of cardiac monitoring. As healthcare shifts towards more patient-centric approaches, the demand for mobile systems that enable continuous, real-time data transmission for cardiology patients is surging. These systems not only empower patients with greater mobility but also facilitate timely medical interventions for healthcare providers. The integration of advanced analytics and connectivity in mobile cardiac telemetry is further propelling market growth, as stakeholders increasingly recognize the value of remote monitoring in improving patient outcomes and reducing healthcare costs.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Mobile Cardiac Telemetry Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • lead based
  • patch based

Global Mobile Cardiac Telemetry Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • cardiac centres
  • others

Global Mobile Cardiac Telemetry Market Size & CAGR (2026-2033)

  • North America (Application, Type)
    • US
    • Canada
  • Europe (Application, Type)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Application, Type)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Application, Type)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Application, Type)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • iRhythm Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Preventice Solutions (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ScottCare Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Applied Cardiac Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medicomp, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CardioNet, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LifeWatch AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bittium Corporation (Finland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hillrom Holdings, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AliveCor, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InfoBionic, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations